TABLE 2.

Mild adverse events, characteristics of patients, and electroconvulsive therapy (ECT) parameters.

	Participants		Significance
	N	%	c2	p
Gender
Male	8	4.7	0.762	0.383
Female	31	6.6
Diagnosis
F06	0	0.0	2.706	0.745
F20	2	2.8
F25	3	4.8
F31	7	8.1
F32	1	3.7
F33	26	6.7
Type of ECT treatment
Maintenance course (1 session)	10	2.5	26.654	<0.0001
Series of ECT sessions	29	12.4
	Mean	Std	T	p
Age
Total			1.669	0.096
No adverse events (n = 599)	56.47	15.03
Mild adverse events (n = 39)	60.62	15.19
Anesthesia (mg propofol)
Total	124.70	29.65	1.149	0.251
No adverse events (n = 599)	125.03	29.73
Mild adverse events (n = 39)	119.39	28.74
Muscle relaxant (mg succinylcholine)
Total	44.06	10.69	0.071	0.943
No adverse events (n = 599)	44.05	10.65
Mild adverse events (n = 39)	43.93	11.70
Stimulus dose (mA)
Total	0.53	0.13	2.011	0.045
No adverse events (n = 599)	0.52	0.13
Mild adverse events (n = 39)	0.57	0.12
Sessions per stay
Total	4.87	6.63	2.683	0.007
No adverse events (n = 599)	4.71	6.58
Mild adverse events (n = 39)	7.64	7.05